Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Hemlibra subcutaneous injection approved in Japan for hemophilia A without inhibitors

Dec. 24, 2018

FDA grants early approval for Ultomiris for the treatment of adults with PNH

Dec. 24, 2018

Rivaroxaban thromboprophylaxis effective only during treatment period in cancer patients

Dec. 24, 2018

Novel anti-BMP6 targeted antibody reduces the need for EPO in anemia of chronic disease models

Dec. 21, 2018

Selatogrel significantly inhibits platelet aggregation in phase II studies

Dec. 19, 2018

China becomes first country to approve roxadustat

Dec. 18, 2018

FLT180a gene therapy safe in first two hemophilia B patients in clinical trial

Dec. 5, 2018

University of Pennsylvania divulges anti-PF-4 antibodies

Dec. 5, 2018

ASH 2018: Multiple studies give new insights into clotting cascade

Dec. 4, 2018

Bayer presents first phase I data for BAY-1093884 in patients with hemophilia

Dec. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...